CMMB
Chemomab Therapeutics
CMMB
CMMB
14 hedge funds and large institutions have $10.6M invested in Chemomab Therapeutics in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$216K | |
| 2 | +$100K | |
| 3 | +$45.6K | |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$3.66K |
| 5 |
Morgan Stanley
New York
|
+$1.28K |
Top Sellers
| 1 | -$71K | |
| 2 | -$53K | |
| 3 | -$2.02K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$832 |